These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30104245)

  • 1. Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy.
    Spangler JB; Trotta E; Tomala J; Peck A; Young TA; Savvides CS; Silveria S; Votavova P; Salafsky J; Pande VS; Kovar M; Bluestone JA; Garcia KC
    J Immunol; 2018 Oct; 201(7):2094-2106. PubMed ID: 30104245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms.
    Spangler JB; Tomala J; Luca VC; Jude KM; Dong S; Ring AM; Votavova P; Pepper M; Kovar M; Garcia KC
    Immunity; 2015 May; 42(5):815-25. PubMed ID: 25992858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
    VanDyke D; Iglesias M; Tomala J; Young A; Smith J; Perry JA; Gebara E; Cross AR; Cheung LS; Dykema AG; Orcutt-Jahns BT; Henclová T; Golias J; Balolong J; Tomasovic LM; Funda D; Meyer AS; Pardoll DM; Hester J; Issa F; Hunter CA; Anderson MS; Bluestone JA; Raimondi G; Spangler JB
    Cell Rep; 2022 Oct; 41(3):111478. PubMed ID: 36261022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3
    Abo H; Flannigan KL; Geem D; Ngo VL; Harusato A; Denning TL
    Front Immunol; 2019; 10():459. PubMed ID: 30930900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases.
    Xu L; Song X; Su L; Zheng Y; Li R; Sun J
    Int Immunopharmacol; 2019 Jul; 72():322-329. PubMed ID: 31005777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
    Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
    Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.
    Zhu X; Liu Z; Liu JQ; Zhu J; Zhang J; Davis JP; Chu J; Yu J; Zhou J; Li MS; Bai XF
    J Leukoc Biol; 2016 Aug; 100(2):403-11. PubMed ID: 27106672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells treated by Trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice.
    Jin X; Yang Y; Bai X; Shi H; Zhang W; Zhang Z; Jia W; Lin J; Liu M; Liu X
    Int Immunopharmacol; 2019 May; 70():378-386. PubMed ID: 30852293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
    de Zoeten EF; Hancock WW
    Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583
    [No Abstract]   [Full Text] [Related]  

  • 12. Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia.
    Liu R; Zhou Q; La Cava A; Campagnolo DI; Van Kaer L; Shi FD
    Eur J Immunol; 2010 Jun; 40(6):1577-89. PubMed ID: 20352624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.
    Suri-Payer E; Cantor H
    J Autoimmun; 2001 Mar; 16(2):115-23. PubMed ID: 11247637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
    Peraino JS; Zhang H; Rajasekera PV; Wei M; Madsen JC; Sachs DH; Huang CA; Wang Z
    J Immunol Methods; 2014 Mar; 405():57-66. PubMed ID: 24462799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice.
    Mullins GN; Valentine KM; Al-Kuhlani M; Davini D; Jensen KDC; Hoyer KK
    Sci Rep; 2020 Dec; 10(1):21994. PubMed ID: 33319815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
    Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
    Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation.
    Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH
    Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.
    Ballesteros-Tato A
    Immunotherapy; 2014; 6(11):1207-20. PubMed ID: 25496335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
    Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
    J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.